Dr. Hammerman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
450 Brookline Ave
Dana Farber Cancer Institute
Boston, MA 02215Phone+1 617-632-3000- Is this information wrong?
Education & Training
Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2008 - 2011
Massachusetts General HospitalResidency, Internal Medicine, 2006 - 2008
Perelman School of Medicine at the University of PennsylvaniaClass of 2006
Certifications & Licensure
MA State Medical License 2008 - 2025
Clinical Trials
- Ponatinib for Squamous Cell Lung and Head and Neck Cancers Start of enrollment: 2013 Jan 01
- A Phase I/II Study of MLN0128 in Metastatic Anaplastic Thyroid Cancer and Incurably Poorly Differentiated or Radioidodine Refractory Differentiated Thyroid Cancer Start of enrollment: 2015 Jul 01
Publications & Presentations
PubMed
- 1 citationsExpressed Barcoding Enables High-Resolution Tracking of the Evolution of Drug Tolerance.Jennifer L Cotton, Javier Estrada Diez, Vivek Sagar, Julie Chen, Michelle Piquet, John Alford, Youngchul Song, Xiaoyan Li, Markus Riester, Matthew T DiMare, Katja Schu...> ;Cancer Research. 2023 Nov 1
- 32 citationsSex-biased ZRSR2 mutations in myeloid malignancies impair plasmacytoid dendritic cell activation and apoptosis.Katsuhiro Togami, Sun Sook Chung, Vikas Madan, Christopher A G Booth, Christopher M. Kenyon, Lucia Cabal-Hierro, Justin Taylor, Sunhee S. Kim, Gabriel K. Griffin, Mahm...> ;Cancer Discovery. 2021 Oct 6
- 60 citationsULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1 mutant lung cancerJiehui Deng, Aatish Thennavan, Igor Dolgalev, Ting Chen, Jie Li, Antonio Marzio, John T. Poirier, David H. Peng, Mirna Bulatović, Subhadip Mukhopadhyay, Heather Silver...> ;Nature Cancer. 2021 May 1
- Join now to see all
Journal Articles
- Author Correction: EZH2 Inhibition Sensitizes BRG1 and EGFR Mutant Lung Tumours to TopoII InhibitorsPeter Hammerman, MD, Nature
- Genomic Correlates of Response to Immune Checkpoint Blockade in Microsatellite-Stable Solid TumorsJeffrey A Engelman, David A Barbie, Nicole G Chau, Glenn J Hanna, Natalie I Vokes, Sabina Signoretti, Pasi A Janne, Robert I Haddad, Lynette M Sholl, Rizwan Haq, Peter..., Nature
- Exome and Genome Sequencing of Nasopharynx Cancer Identifies NF-κB Pathway Activating MutationsSimion I Chiosea, Peter S Hammerman, Jennifer R Grandis, Nicole G Chau, Nature
Press Mentions
Chutes & Ladders—J&J Science Chief Stoffels the Latest C-suite Leader to RetireOctober 15th, 2021- After 15 Years Helping Lead Early Cancer Research at Genentech, Malek Jumps Ship to Run Novartis' NIBR Oncology UnitOctober 14th, 2021
- Flagship Keeps Ex-FDA Commish Stephen Hahn Busy with Another CMO Gig; Daphne Koller Makes Key Hire at Insitro by Welcoming Google and Facebook VetSeptember 10th, 2021
- Join now to see all
Hospital Affiliations
Dana-Farber Cancer InstituteBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
